In Vitro Activity of Two Nanoparticles on Clinical Isolates of Candida parapsilosis, Showing Resistance Against Antifungal Agents in Children

AuthorEnsieh Lotfalien
AuthorAhmad Reza Shahverdien
AuthorRasoul Mohammadien
AuthorFatemeh Noorbakhshen
AuthorAli Ghajarien
AuthorSaham Ansarien
AuthorSassan Rezaieen
OrcidEnsieh Lotfali [0000-0001-6709-1320]en
OrcidRasoul Mohammadi [0000-0002-8220-4511]en
OrcidSassan Rezaie [0000-0001-6709-1320]en
Issued Date2017-10-31en
AbstractBackground: Resistance of pathogenic fungi to conventionally available antifungal agents has been increasing and has become a serious problem. On the other hand, nanoscience has emerged as a powerful tool capable of developing and designing new antimicrobial drugs. Objectives: The aim of this study was to test minimum inhibitory concentrations (MICs) of silver (Ag-NPs) and selenium (Se-NPs) nanoparticles, both alone and in combination with antifungal agents fluconazole (FLU), itraconazole (ITR), and amphotericin B (AMB) on resistant C. parapsilosis strains. Methods: Eight C. parapsilosis strains resistant to antifungal agents (FLU, ITR, AMB) and the standard strain of C. parapsilosis (ATCC 22019) as a control were used in this study. The standard protocol of antifungal susceptibility testing for yeast was performed by the broth micro-dilution method described in the clinical and laboratory standards institute (CLSI) guidelines, document M 27-S4. Results and Conclusions: MICs of standard and resistant strains were different against nano compounds, both alone and in combination with antifungal drugs. The growth of yeast was inhibited by Ag-NPs at concentrations as low as 2 µg /mL (against FLCR1 and FLCR3) and 0.25 µg /mL (against ITRR2 and AMBR2). Antifungal activity testing of Se-NPs revealed that it can inhibit the growth of yeasts at concentrations as low as 4 µg /mL (against FLCR1 and FLCR3) and 0.5 mg/mL (against ITRR2, ITRR3 and AMBR1). The results demonstrated that Se-NPs had lower activity than Ag-NPs, but both (Se-NPs and Ag-NPs) had higher activity than common antifungal agents. Further in vitro and in vivo studies are required for this.en
DOIhttps://doi.org/10.5812/archcid.13853en
URIhttps://brieflands.com/journals/archcid/articles/13853en
KeywordNanoparticlesen
KeywordFungal Drug Sensitivity Testsen
Keyword<i>Candida parapsilosis</i>en
PublisherBrieflandsen
Title<i>In Vitro</i> Activity of Two Nanoparticles on Clinical Isolates of <i>Candida parapsilosis</i>, Showing Resistance Against Antifungal Agents in Childrenen
TypeResearch Articleen

Files